Recalled knee revisions cloud Smith & Nephew bright first quarter
This article was originally published in Clinica
Executive Summary
An increase in the number of patients who required revision surgery after receiving Smith & Nephew cement-free knee implants which were withdrawn last August provided the one cause for concern in an otherwise positive first quarter for the UK company, which has just reported underlying sales growth of 12% (+9% reported) to £302m ($540m).